Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
An infectious disease doctor in California receives the Pfizer vaccine on Thursday, Dec. 17. Photo: Keith Birmingham/MediaNews Group/Pasadena Star-News via Getty
Pfizer vaccine vials contain extra doses that could boost America's supply by up to 40%, the Food and Drug Administration announced on Wednesday.
Driving the news: The U.S. has 100 million doses of the Pfizer-BioNTech vaccine to inoculate 50 million people but declined to buy more doses earlier this year. The vaccine is first being administrated to frontline health care workers and nursing home residents and staff.
- Extra doses could expand the country's inventory, and help mitigate the possibility of demand eclipsing supply, Politico, which first reported the news, writes.
What they're saying: "At this time, given the public health emergency, FDA is advising that it is acceptable to use every full dose obtainable (the sixth, or possibly even a seventh) from each vial, pending resolution of the issue," the FDA tweeted Wednesday evening.
- The agency explained it was working with Pfizer to determine “the best path forward."
- But, but, but: "The amount of vaccine remaining in the multidose vial after removal of 5 doses can vary, depending on the type of needles and syringes used," Pfizer said in a statement.
- "At this time, we cannot provide a recommendation on the use of the remaining amount of vaccine from each vial. Vaccinators need to consult their institution’s policies for the use of multidose vials."
The state of play: Pfizer's glass vials were expected to contain five doses, but pharmacists noticed enough for six to seven.
- Federal health officials are telling states to use the extra doses — without contaminating across multiple vials — in an effort to meet demand as coronavirus cases continue to surge across the U.S.
- The U.S. hit a record 300,000 coronavirus-related deaths on Monday.
Context: The Trump administration is negotiating with Pfizer to purchase additional doses, but the pharmaceutical company might not be able to provide more vaccines until summer 2021, per Politico.
- Moderna, the only other company whose COVID-19 vaccine has been deemed safe and "highly effective" by the FDA, has agreed to provide doses for 200 million people by the end of June.